Roger Jeffs Email

CEO . Liquidia Technologies

Current Roles

Employees:
111
Revenue:
$17.2M
About
Liquidia Technologies is a biopharmaceutical company transforming the development of new therapies by precisely engineering drug particles. Our proprietary PRINT technology is a simple, elegant solution that solves common problems with drug delivery and efficacy. PRINT technology is a scalable cGMP compliant process that creates particles and can apply to virtually any therapeutic area, molecule or route of administration. Liquidia is bringing more efficient, controlled development capabilities to the industry while enhancing the safety and quality of products for patients. Liquidia is advancing product candidates from its own pipeline. These initial product candidates, LIQ861 and LIQ865, apply the PRINT technology to better drug delivery in inhaled and pain therapeutic areas, respectively. The PRINT technology is also licensed with world-leading pharmaceutical companies that are developing future product candidates.
Liquidia Technologies Address
419 Davis Drive
Morrisville, NC
United States
Liquidia Technologies Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.